Details for Patent: 8,763,222

Which drugs does patent 8,763,222 protect, and when does it expire?

Patent 8,763,222 protects SINUVA and is included in one NDA.

This patent has four patent family members in four countries.

Summary for Patent: 8,763,222

Title:	Methods and devices for crimping self-expanding devices
Abstract:	Described here are devices and methods for crimping self-expanding devices. The crimping devices may be useful for crimping a variety of different self-expanding devices (whether such devices are biodegradable or bio-durable). The crimping devices may have crimping members to engage the self-expanding device to reduce the device from an expanding configuration to an unexpanded configuration. The crimping member may comprise or include a suture, wire, ribbon, guiding hoop, pusher, prong, holding bar, balloon, jaws, combinations thereof, or the like. The crimping devices may also include or comprise a holding structure to hold the self-expanding device in an unexpanded or expanded configuration.
Inventor(s):	Abbate; Anthony J. (Santa Clara, CA), Huang; Bin (Pleasanton, CA), Zaler; Gail M. (Milpitas, CA), Gale; David C. (San Jose, CA), Kaufman; Richard E. (Los Gatos, CA), Rajasekhar; Vijaykumar (Apple Valley, CA)
Assignee:	Intersect ENT, Inc. (Palo Alto, CA)
Application Number:	12/512,855
Patent Claim Types: see list of patent claims	Delivery; Device;

Drugs Protected by US Patent 8,763,222

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Intersect Ent Inc	SINUVA	mometasone furoate	IMPLANT;IMPLANTATION	209310-001	Dec 8, 2017		RX	Yes	No			Y

International Family Members for US Patent 8,763,222

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009276505
Canada	2732355
European Patent Office	2320832